Indeed, some of the drugs or their targets, for example, tretinoin targeting RAR genes and GW‐8510 targeting CDK2 and CDK5, were previously linked to neuroprotective functions or neurodegenerative diseases. This evidence concerns the gene CDK5 and neurodegenerative disease.